229 results about "Middle ear" patented technology

Apparatus and method for treating a disease or condition of the ear, such as Meniere's disease or endolymphatic hydrops, includes a manual device operable by hand to pressurize air and pressure transmitting arrangement for delivering the pressurized air to the middle ear, preferably in pulses, to displace the partition between the middle ear and the inner ear to influence fluid in the inner ear.

The invention provides a flexible ear tube (10) for draining and ventilating the middle ear, the tube (10) having a flexible substantially tubular stem (12) with a lumen (14), the stem (12) being sized to be inserted through an incision in the eardrum (16) and the tube having at least two separate flexible contact surfaces (18) extending from the stem (12) and adapted to engage different spaced-apart inner surfaces of the eardrum 16, each of the contact surfaces (18) having a first axis XX extending substantially perpendicularly to the central axis of the stem and a second axis YY extending substantially perpendicularly to the first axis wherein one of the axes is between 0.6 and 3 mm and the second of the axes is between 1 and 7 mm in length.

An implantable hearing aid transducer apparatus provides a simplified approach for interface with a middle ear component. The transducer includes a transducer housing, an actuator for middle ear coupling, and a driver having a magnet or coil interconnected to the actuator to induce movement in response to driver signals. In one feature, the actuator may be advanceable through an aperture of the housing independent from operation of the driver. In another feature, a portion of the transducer may be rotatable. In another feature, a retention apparatus may function to selectively secure a rotatable portion of the housing in a selected position. In an additional feature, a seal may be disposed around a driver component and connected to the actuator.

The invention relates to a method for objectively and quantifiably evaluating noise fret degree in a vehicle based on an auditory model, in particular to an evaluation method of psychoacoustics and vehicle sound quality. The method comprises the following steps: designing a dummy head model; imitating a processing mechanism of the middle ear and the inner ear of a human body to the sound by usingan auditory peripheral calculation model; collecting vehicle noise signals under the working conditions of uniform, accelerated and idle speed; pre-treating the noise sample and processing the loudness in specification; obtaining a psychoacoustics parameter by using a sound quality calculation model; obtaining subjective evaluation result test data by using a grouped and paired comparison method;calculating and painting a correlated scatter plot chart between each parameter and the ranking value of the subjective evaluation result; and analyzing and calculating to obtain the objectively quantifiable model of the subjective fret degree under each working condition. The invention can realize the psychoacoustic parameter calculation of objectively evaluating the sound quality with differentvehicle types, gears and speeds, wherein the calculated value has good pertinence and consistency with the evaluated result of the subjective evaluation method. The invention has stable evaluated result and high reliability, and can improve the sound quality and competitiveness of vehicles combined with the design of new CAE cars.

Chronic Otitis Media with Effusion (COME), Recurrent Acute Otitis Media (RAOM), cholesteatoma, and other bacterial ear conditions may be treated by applying a solvating system containing greater than 0.2 wt. % surfactant to a bacterial biofilm in the middle or inner ear, disrupting the biofilm, and applying a protective layer of a polymeric film-forming medical sealant.

There is provided hearing device improvements using modulation techniques adapted to the characteristics of auditory and vestibular hearing. One embodiment provides for extending hearing to the infrasonic range by extracting sounds from the high ambient noise in this range and applying them to a carrier in the ultrasonic quiet zone. Further extension of hearing into the ultrasonic range is provided by a modulation scheme which uses a fluid conduction coupler to match impedance for a vibration transducer applied to the skin. A variation on this embodiment integrates this ultrasonic hearing extension with normal acoustic headphones. Another embodiment compensates for high frequency hearing loss by a modulation scheme which uses middle ear resonance as an amplifier. A further embodiment combines ultrasonic transposition with wireless modulation to obtain secure communication.

Chronic otitis media and other bacterial ear conditions may be treated by applying a solvating system containing a metal ion sequestering agent and surfactant to a bacterial biofilm in the middle or inner ear. The solvating system disrupts the biofilm and aids in its removal.

A simple cochlear implant is provided that avoids excavation of the mastoid bone. The cochlear implant includes one or more modules for housing the active and passive electronics, and an electrode array for stimulating the nerves of the cochlea. The cochlear implant may include a single modular unit which houses all of the electronics including processor, power supply and microphone. The single modular unit is positioned within the soft tissue behind the ear pinna. Alternatively, the cochlear implant includes two modular units. The first module is implanted within the soft tissue between the ear pinna and mastoid bone. Meanwhile, the second unit is an external module which may be positioned at various external locations. The exterior module may transmit electrical signals to the implanted module through various communication connections including direct electrical contact or through an electromagnetic link. The electrode array is surgically routed from the implanted module in the soft tissue to the cochlea without entering the ear canal by positioning the electrode array between the mastoid bone and the skin of the auditory canal. The electrode array is then routed around the tympanic membrane and through the middle ear to the cochlea. In addition, may be routed along a channel formed in the mastoid bone or through a hole formed in the Spine of Henle for further supporting the electrode array.

There is provided hearing device (140) improvements using modulation techniques adapted to the characteristics of auditory and vestibular hearing. One embodiment provides for extending hearing to the infrasonic range and applying them to a carrier in the ultrasonic “quiet zone”. Further extension of hearing into the ultrasonic range is provided by a modulation scheme which uses a fluid conduction coupler to match impedance for a vibration transducer applied to the skin. A variation on this embodiment integrates this ultrasonic hearing extension with normal acoustic headphones. Another embodiment compensates for high frequency hearing loss by a modulation scheme which uses middle ear resonance as an amplifier. A further embodiment combines ultrasonic transposition with wireless modulation to obtain secure communication.

The invention relates to the polynucleotide sequence of a nontypeable stain of Haemophilus influenzae (NTHi) and polypeptides encoded by the polynucleotides and uses thereof. The invention also relates to NTHi genes which are upregulated during or in response to NTHi infection of the middle ear and / or the nasopharynx.

This disclosure provides a method for detecting and / or identifying uncultured bacteria. The sample is an aerosol sample selected from a group consisting of cough, sneeze, saliva, mucus, bile, urine, vaginal secretions, middle ear aspirate, pus, pleural effusions, synovial fluid, abscesses, cavity swabs, serum, blood and spinal fluid. The method comprises obtaining absorption spectra (AS) of the sample, extracting and processing the acquired data, thereby detecting and / or identifying the bacteria.

An electrophysiological measurement method and system is provided for positioning an implantable transducer of a hearing instrument relative to a middle ear component or inner ear of a patient. The method and system employ electrophysiological measurement signals obtained in response to test signals applied to an implanted transducer. In one embodiment, the electrophysiological measurements are obtained by an electrocochleography measurement device that measures the cochlear summating potential and / or action potential responsive to test signals applied to an implanted transducer. In another embodiment, an auditory brainstem response measurement device is utilized to obtain electrical potential measurement signals responsive to test signals applied to an implanted transducer.